Intima Bioscience to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of its solid tumor cell-therapy…
adminFebruary 7, 2022
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and…
adminFebruary 6, 2022
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and…
adminJanuary 31, 2022
- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md.,…
adminJanuary 31, 2022
Board of Directors Elects New Chair, Vice-Chair, and Two New Members ROCKVILLE, MARYLAND, January 31, 2021 – The Board of…
adminJanuary 31, 2022
POSITION DESCRIPTION – Entrepreneur-In-Residence EIRs will work in collaboration with SEED to mentor innovators and provide guidance to help them…
adminJanuary 31, 2022
The current boom in life sciences development mirrors the tech industry, especially geographically; there is an incredible concentration of jobs…
adminJanuary 31, 2022
Global public health is at a critical inflection point. Do we learn the lessons of this pandemic and build a…
adminJanuary 31, 2022
The Novavax vaccine would be the first protein-based alternative available in Israel GAITHERSBURG, Md., Jan. 28, 2022 /PRNewswire/ -- Novavax,…
adminJanuary 31, 2022